Lymphoma is one of the hematologic malignancies that occur at a higher rate in human
immunodeficiency virus-infected individuals. It is one of the most frequent neoplastic causes …

Histone modifications are an epigenetic mechanism, and the dysregulation of these proteins
is known to be associated with the initiation and progression of cancer. In the search for the …

The improvements in magnetic resonance imaging (MRI) technology and the concern
related to the increased cancer risk in patients with lymphoma, also due to radiation …

Objectives To evaluate whether template-based structured reports (SRs) add clinical value
to primary CT staging in patients with diffuse large B-cell lymphoma (DLBCL) compared to …

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphoid
malignancies, which counts for more than a third of non-Hodgkin's lymphoma cases. The …

B-cell lymphoma cells depend upon cholesterol to maintain pro-proliferation and pro-
survival signaling via the B-cell receptor. Targeted cholesterol depletion of lymphoma cells …

Rosai–Dorfman disease (RDD) is an uncommon benign entity characterized histologically
by lymphatic sinus dilatation due to histiocyte proliferation. This study was performed to …

Background: Acquired immune deficiency syndrome (AIDS)-related non-Hodgkin lymphoma
(AR-NHL) is a high-risk factor for morbidity and mortality in patients with AIDS. This study …

Imaging of lymphoma is based on the use of 18F-fluorodeoxyglucose positron emission
tomography/computed tomography (18F-FDG-PET/CT) and/or contrast-enhanced CT, but …

Background Assessment of bone marrow involvement (BMI) in non‐Hodgkin lymphoma
(NHL) is crucial for determining patient prognosis and treatment strategy. We assessed the …